The new-generation therapeutic anti-CD25 monoclonal antibodies.
Williams
K A
KA
Department of Ophthalmology, Flinders University, Adelaide, Australia.
Thiel
M A
MA
Zola
H
H
D000911:Antibodies, Monoclonal / Q000493:pharmacokinetics* / Q000494:pharmacology; D000077552:Basiliximab; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007166:Immunosuppressive Agents / Q000493:pharmacokinetics*; D016030:Kidney Transplantation; D015375:Receptors, Interleukin-2 / Q000276:immunology; D011993:Recombinant Fusion Proteins
D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D015375:Receptors, Interleukin-2; D011993:Recombinant Fusion Proteins; D000077552:Basiliximab